TRex Bio raised $116.7 million in a U.S. IPO, pricing at the bottom of its range
- U.S. IPO: 6 events in the last 90 days
- Previous: earlier the same day · 7-Eleven's U.S. IPO timing will hinge on turnaround progress, CEO says
What happened
The clinical-stage biotech sold about 8.3 million shares at $14 each, the low end of its $14-to-$16 marketed range
Summary assembled by rule from the sources below